Search Results 11-20 of 8303 for TNF

1. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

   ... Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite ...

2. Weekend Wellness: Ankylosing spondylitis symptom changes hard to predict

   TNF stands for tumor necrosis factor — a cell protein that leads to inflammation. TNF blockers target this protein to help reduce pain, stiffness, and ...

3. Adrian T. Ting, Ph.D. - Mayo Clinic Faculty Profiles

   Ting's lab studies primarily post-translational mechanisms that dictate cell survival versus death in response to tumor necrosis factor (TNF). Even though TNF ...

4. Mayo Clinic Q and A: With psoriatic arthritis, the sooner therapy is started, the better

   Immunosuppressants — These medications act to tame your immune system, which is out of control in psoriatic arthritis. Tumor necrosis factor-alpha (TNF-alpha) ...

5. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

   ... Tumor Necrosis Factor (TNF) therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

6. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

   A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.

7. A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF Alpha Inhibitor - Mayo Clinic

   A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF Alpha Inhibitor.

8. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

   Have had anti-tumor necrosis factor (TNF)-alpha therapy and were unresponsive by 1 of the following 2 reasons: Lack of benefit to at least 1 anti-TNF-alpha ...

9. Sacroiliitis - Diagnosis and treatment - Mayo Clinic

   Tumor necrosis factor (TNF) inhibitors include etanercept (Enbrel), adalimumab (Humira), infliximab (Remicade) and golimumab (Simponi). Both types of ...

10. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    Also known as TNF inhibitors, these medicines work by neutralizing an immune system protein known as tumor necrosis factor (TNF). Ustekinumab (Stelara) ...